Trial Profile
The Role of Inflammation in Central Nervous System (CNS) Mechanisms of Anhedonia and Psychomotor Slowing in Depressed People With HIV
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2024
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary)
- Indications Anhedonia; Bipolar depression; Depression
- Focus Therapeutic Use
- 16 Nov 2023 Status changed from not yet recruiting to recruiting.
- 18 Sep 2023 Planned initiation date changed from 1 Oct 2023 to 16 Oct 2023.
- 13 Sep 2023 Planned initiation date changed from 1 Aug 2023 to 1 Oct 2023.